Clinical Trial Update: Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO [NA]

View source ↗

Summary

Clinical trial update for allogeneic stem cell transplantation in severe beta-thalassemia variants; the study is terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Thalassemia

Snippet

Sponsor: Baylor College of Medicine | Conditions: Thalassemia | NA | Status: TERMINATED | Results posted: 2020-05-01